Shorting stocks has been a coin-flip in 2025, with almost 50% of short positions unprofitable this year, S3 Partners said.

Short sellers have faced staggering losses exceeding $250 billion in the latest market rally, with Nvidia (NVDA) and Tesla ...

The market's rapid bounce back to near record highs over the past month has not been kind to investors betting against US ...

CoreWeave Inc. shares have been on a tear as investors snap up the stock despite widespread concerns about elevated debt ...

Culper Research has announced a new short position against electric vertical take-off and landing (eVTOL) aircraft developer ...

After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S.

Understand the potential for a market-wide short squeeze due to aggressive trading and how it impacts stock prices.

Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...

Learn how Canada is speaking against naked short selling, a practice that distorts markets and erodes trust among investors.

Ethena whales exit with losses despite signs of a possible price recovery. Could their sell-off have come at the wrong time ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

Stocks with extremely short interests are prone to short squeezes — triggering rapidly rising prices because lots of short-sellers are holding positions. When a short squeeze occurs, many short ...